PET imaging of opioid receptors in pain: Progress and new directions

Hayden T. Ravert, Badreddine Bencherif, Igal Madar, J. James Frost

Research output: Contribution to journalReview articlepeer-review

Abstract

The endogenous opioid system plays a central role in pain. Recent advances have permitted imaging of opioid receptors by PET in human subjects while experiencing pain and detection of changes in receptor occupancy. The ability to perform these types of studies is dependent on the development of opioid tracer ligands labeled with positron emitting isotopes. This article follows the development and radiochemistry of opioid tracer molecules through their use in human subjects and subsequent application to the study of pain. The role of mu, delta and kappa opioid receptors in pain is reviewed. Occupancy changes in mu receptors have been observed with PET in human subjects subjected to experimental pain paradigms. The implication of this approach to the study of pain and pain syndromes, and possible clinical applications, is also addressed

Original languageEnglish (US)
Pages (from-to)759-768
Number of pages10
JournalCurrent pharmaceutical design
Volume10
Issue number7
DOIs
StatePublished - Mar 15 2004

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'PET imaging of opioid receptors in pain: Progress and new directions'. Together they form a unique fingerprint.

Cite this